Covid-19 patients respond positively to remdesivir in major US trial
A vial of the drug Remdesivir is viewed during a press conference about the start of a study on the Ebola drug in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany, on April 8, 2020, amidst the new coronavirus Covid-19 pandemic. PHOTO | ULRICH PERREY | POOL | AFP
Though it is difficult to precisely quantify the finding in the absence of results, it represents the first time any drug has been shown to improve outcomes against the Covid-19 illness.
A summary of results posted on the website of the World Health Organization showed it failed in a smaller Chinese trial, but days before that, Stat reported it had shown significant efficacy at a Chicago hospital.
Washington,
Gilead Science's remdesivir, one of the most highly anticipated drugs being tested against the new coronavirus, showed positive results in a large-scale US government trial, the company said Wednesday.
